• About
  • Partnerships
  • Challenges
  • Awards
  • Grant Opportunities
  • News

Cyclic Peptides for Eliminating Drug-Tolerant Tuberculosis

Anthony Baughn of the University of Minnesota in the U.S. will test a library of cyclic peptides to identify small molecules that impair the ability of the tuberculosis- causing bacterium M. tuberculosis to develop resistance to current drug therapies, for use in a new class of tuberculosis antibiotics.

More information about Explore New Solutions for Global Health Priority Areas (Round 9)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit www.grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.